NRBO Company Profile and Key Details
NeuroBo Pharmaceuticals, Inc.
NRBO Stock Price Chart
Stock Price Today
NeuroBo Pharmaceuticals, Inc. (NRBO) stock remained unchanged at -, trading at $2.36 on NASDAQ, unchanged from the previous close of -. The stock opened at -, fluctuating between $2.36 and $2.36 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Company Information
| Employees | 8 |
| Beta | -0.28 |
| Sales or Revenue | $7.00K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) stock price is $2.36 in the last trading session. During the trading session, NRBO stock reached the peak price of $2.36 while $2.36 was the lowest point it dropped to. The percentage change in NRBO stock occurred in the recent session was N/A while the dollar amount for the price change in NRBO stock was -.
The NASDAQ listed NRBO is part of Biotechnology industry that operates in the broader Healthcare sector. NeuroBo Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Ben Gil Price M.D.
Chief Executive Officer & Pres
Mr. Frank Kondrad
Vice President of Corporation & Bus. Devel.
Dr. Matthew Bardin BCPS, Pharm.D.
Senior Vice President of Operations
Mr. Joseph Hooker
Interim Chief Executive Officer & Pres
NRBO's closing price is 0% higher than its 52-week low of $2.36 where as its distance from 52-week high of $2.36 is 0%.
Number of NRBO employees currently stands at 8.
Official Website of NRBO is: https://www.neurobopharma.com
NRBO could be contacted at phone 857 702 9600 and can also be accessed through its website. NRBO operates from 200 Berkeley Street, Boston, MA 02116, United States.
NRBO stock volume for the day was 0 shares. The average number of NRBO shares traded daily for last 3 months was 0.
The market value of NRBO currently stands at $20.33M with its latest stock price at $2.36 and 8.62M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com